41 results on '"Howell, Charles D."'
Search Results
2. Rheumatologic Diseases and the Liver
3. Unique metabolomic signature associated with hepatorenal dysfunction and mortality in cirrhosis
4. Estimation of Glomerular Filtration Rate in Patients With Cirrhosis by Using New and Conventional Filtration Markers and Dimethylarginines
5. Comparison of functional variants in IFNL4 and IFNL3 for association with HCV clearance
6. Sa1512 Mortality Outcome of Same-Day Versus Different-Day Esophagogastroduodenoscopy and Hemodialysis Among Patients With Renal Failure Admitted for Upper GI Bleeding
7. 413 Comparison of In-Hospital Mortality of Conservative Versus Surgical Management of Peptic Ulcer Perforation in US Hospitals. Is Conservative Management Deadly?
8. Mo1997 Tumor Size Is a Prognostic Factor in Early T Stage Colon Cancer
9. Sa1968 The Association of Patients' Perception of Their Health Status and Being Current With Colorectal Cancer Screening Guidelines
10. Mo1068 Colorectal Cancer Disparities Between Blacks and Hispanics: Healthcare Utilization Versus Biological Differences
11. Tu1070 Association of Chronic Hepatitis C Virus Infection and Cardiovascular Outcomes
12. Phase II study of avatrombopag in thrombocytopenic patients with cirrhosis undergoing an elective procedure
13. Reply to: “Understanding triphasic HCV decline during treatment in the era of IL28B polymorphisms and direct acting antiviral agents via mathematical modeling”
14. The Hepatitis C Crisis in the African American Community: Findings and Recommendations
15. Single nucleotide polymorphism upstream of interleukin 28B associated with phase 1 and phase 2 of early viral kinetics in patients infected with HCV genotype 1
16. Overlap in Pretreatment Hepatic Gene Signatures for Insulin Resistance and Poor Initial Response to Peginterferon and Ribavirin for HCV Genotype 1
17. Changes in Insulin Sensitivity and Body Weight During and After Peginterferon and Ribavirin Therapy for Hepatitis C
18. 6 Outcomes and Predictors of Simultaneous Liver-Kidney Transplantation Among Patients With Kidney Dysfunction Who are Not on Dialysis on the Liver Transplant Waiting List
19. T1973 Gender Disparity and Risk Factors for Hepatocellular Carcinoma in Hospitalized Patients in the United States in 2006
20. 339 Outcomes of Patients With END-Stage Liver Disease on Dialysis for More Than 6 Weeks on the Liver Transplant Waiting List
21. 829 Ribavirin Population Pharmacokinetics in African American and Caucasian American Patients Infected with Chronic Hepatitis C Genotype 1
22. M1767 A Comparative Study of Hepatic Histology of the African-American and Caucasian Hepatitis C Virus Positive Patients with and Without END Stage Renal Disease
23. Peripheral Blood Gene Expression Profile Associated with Sustained Virologic Response after Peginterferon Plus Ribavirin Therapy for Chronic Hepatitis-C Genotype 1
24. Peginterferon Pharmacokinetics in African American and Caucasian American Patients With Hepatitis C Virus Genotype 1 Infection
25. 6 Viral Adaptation to Intrahepatic Immune Response in Poor Virologic Responders to Short-Term Peginterferon Plus Ribavirin Treatment for HCV Genotype (GT) 1
26. 164 Hepatic Gene Trancription Signature Associated with Sustained Virologic Response (SVR) in African (AA) and Caucasian (CA) Americans Infected with HCV Genotype 1
27. Peginterferon and Ribavirin Treatment in African American and Caucasian American Patients With Hepatitis C Genotype 1
28. Risk Factors for Primary Hepatocellular Carcinoma in Black and White Americans in 2000
29. Interferon-Stimulated Gene Expression in Black and White Hepatitis C Patients During Peginterferon Alfa-2a Combination Therapy
30. Association of interferon-α-induced depression and improved treatment response in patients with hepatitis C
31. Racial differences in liver inflammation and fibrosis related to chronic hepatitis C
32. Animal models of autoimmunity
33. Intron-A plus Ribavirin (Rebetron) for the treatment of chronic hepatitis C in prior interferon monotherapy relapsers (RLPs): Final results of the Washington, DC metropolitan area hepatitis C investigators study
34. Does race predict outcome in Intron-A plus Ribavirin (Rebetron) for the treatment of chronic hepatitis C in prior interferon monotherapy non-responders (NRs)? Results of the Washington, DC metropolitan area hepatitis C investigators study
35. Intron-A plus Ribavirin (Rebetron) for the treatment of chronic hepatitis C in prior interferon monotherapy non-responders (NRs): Final results of the Washington, DC metropolitan area hepatitis C investigators study
36. Liver Diseases
37. Distinctive Clinical Features of Portopulmonary Hypertension
38. Murine Experimental Autoimmune Hepatitis: Nonspecific Inflammation Due to Adjuvant Oil
39. Immunogenicity of two recombinant hepatitis B vaccines in older individuals
40. Suppressor function of liver mononuclear cells isolated during murine chronic graft-vs-host disease
41. Suppressor function of hepatic mononuclear inflammatory cells during murine chronic graft-vs-host disease
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.